fool.com · 27 jun

NOV vs. SLB N.V.: Which Energy Stock Is a Better Buy in 2026?

NOV provides a conservative balance sheet with a current ratio of roughly 2.4x and low debt levels. SLB N.V. leverages a massive global footprint to generate substantial free cash flow nearing $4.8 billion.

globenewswire.com · 23 jun

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease

-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary endpoint of endoscopic passability -- -- Study initiation on track, with first participants expected to be dosed in the second half of 2026 -- Antwerp, Belgium, June 23, 2026 – Agomab Therapeutics NV (Nasdaq: AGMB) (“Agomab” or the “Company”), a clinical-stage biopharmaceutical company focused on fibro-inflammation, today announced the design of its upcoming Phase 2b NOV-ERA study with ontunisertib, its investigational oral gastro-intestinal (GI)-restricted small molecule inhibitor of ALK5 (or TGF-β RI) for the potential treatment of Fibrostenosing Crohn's Disease (FSCD). Approximately 46% of Crohn's disease patients have FSCD, or fibrotic strictures in the intestinal tract, which can cause obstructive symptoms leading to dietary change, malnutrition and surgery.

globenewswire.com · 16 jun

NOV Announces Second Quarter 2026 Earnings Conference Call

HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) will hold a conference call to discuss its second quarter 2026 results on Wednesday, July 29, 2026, at 10 a.m. (Central Time).

zacks.com · 9 jun

NOV Stock Gains 32% in Six Months: Should Investors Hold or Move On?

NOV shares rise 32% over the past six months as offshore demand, backlog growth and efficiency gains boost prospects despite tariffs and risks.

zacks.com · 27 may

Why Is Nov Inc. (NOV) Up 4.1% Since Last Earnings Report?

Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock?

globenewswire.com · 21 may

NOV Declares Regular Quarterly Dividend and Supplemental Dividend

HOUSTON, May 21, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock, payable on June 26, 2026 to each stockholder of record on June 12, 2026.

zacks.com · 4 may

Solaris Energy Q1 Earnings Crush Estimates on Power Growth

SEI's Q1 profit jumped 120%, and revenues rose 55% as Power Solutions scaled, aided by behind-the-meter data center power demand.

zacks.com · 1 may

NOV Q1 Earnings Miss Estimates, Revenues Beat, Decrease Y/Y

NOV Q1 earnings miss estimates as Middle East disruptions hit operations, while revenues edge past expectations despite a year-over-year decline.